Prognostic determinants after hepatoportoenterostomy for biliary atresia

Area of Science:

• Pediatric Surgery
• Hepatology
• Neonatal Care

Background:

• Biliary atresia is a severe neonatal liver disease.
• Hepatoportoenterostomy is a surgical procedure to treat biliary atresia.
• Early identification of infants requiring reoperation is crucial for survival.

Purpose of the Study:

• To assess postoperative hepatic secretory functions in infants with biliary atresia.
• To compare these functions between surviving and nonsurviving infants.
• To determine the prognostic significance of these functions for identifying infants needing reoperation.

Main Methods:

• Measured hepatic secretory functions, including alkaline phosphatase clearance, bilirubin clearance, 24-hour secreted bilirubin, and Iodine-131 rose bengal excretion.
• Compared these measurements between surviving and nonsurviving infants at various postoperative time points (1, 4, 12, 24 weeks, and 6 months).

Main Results:

• Significant differences in alkaline phosphatase clearance were observed between survivors and nonsurvivors at 1, 4, 12, and 24 weeks.
• Survivors showed significantly increased bilirubin clearance and 24-hour secreted bilirubin at 12 and 24 weeks.
• Survivors also had significantly increased Iodine-131 rose bengal excretion at 6 months.
• Six of 10 survivors required reoperation due to deteriorating functions, with all improving postoperatively.

Conclusions:

• Postoperative biliary secretory functions have early prognostic significance in infants with biliary atresia.
• These functions can predict which infants may require reoperation.
• Reexploration and improved surgical techniques for atretic ducts may enhance survival rates.